• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,775.74 -1,092.06
( -1.44%)
Global Indices
Nasdaq
51,069.65 379.68
(0.75%)
Dow Jones
7,605.10 20.47
(0.27%)
Hang Seng
66,385.32 1,692.20
(2.62%)
Nikkei 225
10,420.12 -5.84
(-0.06%)
Forex
USD-INR
95.93 0.16
(0.16%)
EUR-INR
111.54 0.10
(0.09%)
GBP-INR
128.71 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

Mac Charles (India) Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
507836
INE435D01014
275.4885496
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MCCHRLS-B
59.58
892.83
EPS(TTM)
Face Value()
Div & Yield %
11.44
10
0
 

novartis india ltd
Concord Biotech consolidated net profit declines 36.75% in the March 2026 quarter
May 30,2026
Net profit of Concord Biotech declined 36.75% to Rs 88.79 crore in the quarter ended March 2026 as against Rs 140.39 crore during the previous quarter ended March 2025. Sales declined 24.15% to Rs 326.08 crore in the quarter ended March 2026 as against Rs 429.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 29.79% to Rs 260.91 crore in the year ended March 2026 as against Rs 371.64 crore during the previous year ended March 2025. Sales declined 12.10% to Rs 1054.89 crore in the year ended March 2026 as against Rs 1200.09 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales326.08429.88 -24 1054.891200.09 -12
OPM %36.2943.94 -34.8342.08 -
PBDT133.62198.16 -33 422.39548.93 -23
PBT114.08183.54 -38 347.93494.55 -30
NP88.79140.39 -37 260.91371.64 -30